Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 2/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5151086 | 0.98 | TAAR1 (0.43) | TAAR1CYP2A6CYP1A2MAOAALDH1A1 | |
| SCHEMBL15787310 | 0.93 | MAOA (0.48) | TAAR1CYP2A6CYP1A2MAOAALDH1A1 | |
| SCHEMBL3849051 | 0.84 | TAAR1 (0.60) | TAAR1CYP2A6CYP1A2ALDH1A1TSHR | |
| SCHEMBL17277598 | 0.84 | TAAR1 (0.50) | TAAR1CYP2A6CYP1A2MAOAHRH1 | |
| SCHEMBL8086639 | 0.84 | NPC1 (0.41) | TAAR1ALDH1A1TSHRNPC1HPGD | |
| SCHEMBL8086536 | 0.84 | PTGS2 (0.42) | TAAR1ALDH1A1TSHRNPC1HPGD | |
| SCHEMBL17277597 | 0.82 | MAOA (0.43) | TAAR1CYP2A6CYP1A2MAOAHRH1 | |
| Hydrochloric Acid SCHEMBL5151143 | 0.82 | TAAR1 (0.58) | TAAR1CYP2A6CYP1A2ALDH1A1TSHR | |
| SCHEMBL8098721 | 0.81 | PTGS2 (0.44) | ALDH1A1TSHRNPC1HPGDMAPK1 | |
| SCHEMBL8086884 | 0.81 | PTGS2 (0.44) | ALDH1A1TSHRNPC1HPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113777195-B | Analysis method of amphetamine drugs in environmental water sample and special graphene-based three-dimensional macroscopic material and solid phase extraction device thereof | 公安部物证鉴定中心 | 2023-10-31 | — | — | CN | disclosed |
| CN-113777195-A | Analysis method of amphetamine drugs in environmental water sample, and special graphene-based three-dimensional macroscopic body material and solid-phase extraction device thereof | 公安部物证鉴定中心 | 2021-12-10 | — | — | CN | disclosed |
| US-20090203708-A1 | NOVEL SUBSTITUTED-1-H-QUINAZOLINE-2,4-DIONE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2009-08-13 | — | — | US | disclosed |
| EP-0525360-B1 | Novel phenylacetamide derivatives and processes for the preparation thereof | KOREA RES INST CHEM TECH (KR) | 1998-03-25 | — | — | EP | disclosed |
| US-5242944-A | Analgesics or antiinflammatory agents | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1993-09-07 | — | — | US | disclosed |
| EP-0525360-A2 | Novel phenylacetamide derivatives and processes for the preparation thereof | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 1993-02-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203708-A1 | NOVEL SUBSTITUTED-1-H-QUINAZOLINE-2,4-DIONE DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | HTR5A, HTR3B, HTR1A | TAAR1 123/4885CYP2A6 295/4885CYP1A2 228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.